Skip to main content

Table 2 Characteristics of experimental groups

From: Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy

  CON STZ
Weight outcomes (n) 10 10
Body weight (g) 438 ± 15 289 ± 14*
Heart weight (mg) 1238 ± 83 840 ± 28*
Heart weight/body weight (mg/g) 2.8 ± 0.2 2.9 ± 0.1
Blood glucose measurement (n) 10 10
Casual glycaemia (mmol/l) 7.4 ± 0.5 20.4 ± 1.79*
Cardiac mRNA expression (n) 9 10
Myh6 (%, relative to controls) 100 ± 5 29 ± 4*
Myh7 (%, relative to controls) 100 ± 17 270 ± 16*
  1. Mean ± SEM, *p < 0.05 versus CON
  2. CON—controls, STZ—streptozotocin administered diabetic rats